DE602006017797D1 - - Google Patents

Info

Publication number
DE602006017797D1
DE602006017797D1 DE602006017797T DE602006017797T DE602006017797D1 DE 602006017797 D1 DE602006017797 D1 DE 602006017797D1 DE 602006017797 T DE602006017797 T DE 602006017797T DE 602006017797 T DE602006017797 T DE 602006017797T DE 602006017797 D1 DE602006017797 D1 DE 602006017797D1
Authority
DE
Germany
Prior art keywords
maytansinoid
anion
ester
maytansinol
disulfide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006017797T
Other languages
English (en)
Inventor
Wayne C Widdison
Ravi V J Chari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunogen Inc
Original Assignee
Immunogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunogen Inc filed Critical Immunogen Inc
Publication of DE602006017797D1 publication Critical patent/DE602006017797D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18Bridged systems
DE602006017797T 2005-01-21 2006-01-20 Active DE602006017797D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64498405P 2005-01-21 2005-01-21
PCT/US2006/001885 WO2006078809A2 (en) 2005-01-21 2006-01-20 Method for the preparation of maytansinoid esters

Publications (1)

Publication Number Publication Date
DE602006017797D1 true DE602006017797D1 (de) 2010-12-09

Family

ID=36692868

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006017797T Active DE602006017797D1 (de) 2005-01-21 2006-01-20

Country Status (14)

Country Link
US (1) US7301019B2 (de)
EP (1) EP1838715B1 (de)
JP (2) JP5425402B2 (de)
AT (1) ATE486077T1 (de)
AU (1) AU2006206421B2 (de)
CA (1) CA2601670C (de)
CY (1) CY1111157T1 (de)
DE (1) DE602006017797D1 (de)
DK (1) DK1838715T3 (de)
ES (1) ES2355153T3 (de)
PL (1) PL1838715T3 (de)
PT (1) PT1838715E (de)
SI (1) SI1838715T1 (de)
WO (1) WO2006078809A2 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7589180B2 (en) 2001-05-11 2009-09-15 Abbott Laboratories Inc. Specific binding proteins and uses thereof
US20100056762A1 (en) 2001-05-11 2010-03-04 Old Lloyd J Specific binding proteins and uses thereof
US7276497B2 (en) * 2003-05-20 2007-10-02 Immunogen Inc. Cytotoxic agents comprising new maytansinoids
US7301019B2 (en) * 2005-01-21 2007-11-27 Immunogen, Inc. Method for the preparation of maytansinoid esters
AU2006280146B2 (en) * 2005-08-09 2012-06-28 Immunogen, Inc. Method of acylating maytansinol with chiral amino acids
WO2008091701A2 (en) 2007-01-25 2008-07-31 Dana-Farber Cancer Institute Use of anti-egfr antibodies in treatment of egfr mutant mediated disease
WO2008115404A1 (en) 2007-03-15 2008-09-25 Ludwing Institute For Cancer Research Treatment method using egfr antibodies and src inhibitors and related formulations
CN101802013B (zh) 2007-07-16 2014-07-02 健泰科生物技术公司 人源化抗cd79b抗体和免疫偶联物及使用方法
NZ583367A (en) 2007-07-16 2012-10-26 Genentech Inc Anti-cd79b antibodies and immunoconjugates and methods of use
CA2696360C (en) 2007-08-14 2018-11-20 Ludwig Institute For Cancer Research Monoclonal antibody targeting the egfr receptor and uses thereof
MX2010008437A (es) 2008-01-31 2010-11-25 Genentech Inc Anticuerpos anti-cd79b e inmunoconjugados y metodos de uso.
WO2010120561A1 (en) 2009-04-01 2010-10-21 Genentech, Inc. Anti-fcrh5 antibodies and immunoconjugates and methods of use
KR20120080611A (ko) 2009-10-06 2012-07-17 이뮤노젠 아이엔씨 효능 있는 접합체 및 친수성 링커
RU2573994C2 (ru) 2010-02-10 2016-01-27 Иммьюноджен, Инк Антитела против cd20 и их применение
JP5889912B2 (ja) 2010-11-17 2016-03-22 ジェネンテック, インコーポレイテッド アラニニルメイタンシノール抗体コンジュゲート
CA2824864C (en) 2011-02-15 2019-04-09 Immunogen, Inc. Cytotoxic benzodiazepine derivatives
US9289512B2 (en) 2011-06-21 2016-03-22 Immunogen, Inc. Maytansinoid derivatives with peptide linker and conjugates thereof
EA027900B1 (ru) 2011-09-22 2017-09-29 Эмджен Инк. Связывающие антиген cd27l белки
CN102731526B (zh) * 2012-05-14 2014-09-10 福建省微生物研究所 安丝菌素类化合物及其制备方法
UY34813A (es) 2012-05-18 2013-11-29 Amgen Inc Proteínas de unión a antígeno dirigidas contra el receptor st2
NZ739573A (en) * 2012-09-26 2019-11-29 Immunogen Inc Improved methods for the acylation of maytansinol
CA2891280C (en) 2012-11-24 2018-03-20 Hangzhou Dac Biotech Co., Ltd. Hydrophilic linkers and their uses for conjugation of drugs to cell binding molecules
TW201425336A (zh) 2012-12-07 2014-07-01 Amgen Inc Bcma抗原結合蛋白質
CN103333246B (zh) 2012-12-21 2015-09-16 百奥泰生物科技(广州)有限公司 一种抗egfr受体的肿瘤生长抑制剂及其制备方法和用途
CN104530235A (zh) 2012-12-21 2015-04-22 百奥泰生物科技(广州)有限公司 一种抑制肿瘤生长的抗体药物衍生物及其制备方法和用途
CN104688740A (zh) 2012-12-21 2015-06-10 百奥泰生物科技(广州)有限公司 类美登素衍生物及其制备方法和用途
CN103254213B (zh) 2012-12-21 2015-02-25 百奥泰生物科技(广州)有限公司 类美登素酯的制备方法及用于所述方法的组合物
ES2728936T3 (es) 2013-01-25 2019-10-29 Amgen Inc Anticuerpos dirigidos contra CDH19 para melanoma
EP2961434A2 (de) 2013-02-28 2016-01-06 ImmunoGen, Inc. Konjugate mit zellbindenden mitteln und zytostatika
PL3004167T3 (pl) 2013-05-30 2019-01-31 Kiniksa Pharmaceuticals, Ltd. Białka wiążące antygen receptora onkostatyny m
US10208125B2 (en) 2013-07-15 2019-02-19 University of Pittsburgh—of the Commonwealth System of Higher Education Anti-mucin 1 binding agents and uses thereof
TWI541022B (zh) 2013-12-18 2016-07-11 應克隆公司 針對纖維母細胞生長因子受體-3(fgfr3)之化合物及治療方法
ES2960619T3 (es) 2014-02-28 2024-03-05 Hangzhou Dac Biotech Co Ltd Enlazadores cargados y sus usos para la conjugación
KR20170129769A (ko) * 2015-03-17 2017-11-27 리제너론 파아마슈티컬스, 인크. 아미노산 아실화 시약 및 이의 사용 방법
TW201711702A (zh) 2015-06-04 2017-04-01 應克隆公司 使用針對纖維母細胞生長因子受體3(fgfr3)之化合物的療法
WO2015151081A2 (en) 2015-07-12 2015-10-08 Suzhou M-Conj Biotech Co., Ltd Bridge linkers for conjugation of a cell-binding molecule
US9839687B2 (en) 2015-07-15 2017-12-12 Suzhou M-Conj Biotech Co., Ltd. Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
CN107417701A (zh) * 2016-03-03 2017-12-01 凯惠科技发展(上海)有限公司 一种美登素酯的制备方法及其中间体
KR102459468B1 (ko) 2016-11-14 2022-10-26 항저우 디에이씨 바이오테크 씨오, 엘티디 결합 링커, 그러한 결합 링커를 함유하는 세포 결합 분자-약물 결합체, 링커를 갖는 그러한 결합체의 제조 및 사용
EP3956332B1 (de) 2019-04-18 2023-02-22 Indena S.p.A. Diasteroselektives verfahren zur herstellung von thiol- oder disulfidhaltigen maytansinoidestern und zwischenprodukten davon
WO2021007435A1 (en) 2019-07-10 2021-01-14 Cybrexa 2, Inc. Peptide conjugates of cytotoxins as therapeutics
CN114302744A (zh) 2019-07-10 2022-04-08 赛博克萨3公司 作为治疗剂的微管靶向剂的肽缀合物
US20230256114A1 (en) 2020-07-07 2023-08-17 Bionecure Therapeutics, Inc. Novel maytansinoids as adc payloads and their use for the treatment of cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55164685A (en) * 1979-06-08 1980-12-22 Takeda Chem Ind Ltd Novel maytansinoid compound and its preparation
JPS55164686A (en) * 1979-06-11 1980-12-22 Takeda Chem Ind Ltd Novel maytansinoid compound and its preparation
US6020507A (en) * 1998-03-02 2000-02-01 Bristol-Myers Squibb Company Synthesis of paclitaxel from baccatin III by protection of the 7-hydroxyl of baccatin III using a strong base and an electrophile
US6333410B1 (en) * 2000-08-18 2001-12-25 Immunogen, Inc. Process for the preparation and purification of thiol-containing maytansinoids
US7301019B2 (en) * 2005-01-21 2007-11-27 Immunogen, Inc. Method for the preparation of maytansinoid esters

Also Published As

Publication number Publication date
CY1111157T1 (el) 2015-06-11
US7301019B2 (en) 2007-11-27
SI1838715T1 (sl) 2011-02-28
PL1838715T3 (pl) 2011-04-29
EP1838715A2 (de) 2007-10-03
EP1838715A4 (de) 2009-06-03
JP2014012693A (ja) 2014-01-23
CA2601670C (en) 2013-04-02
CA2601670A1 (en) 2006-07-27
JP5425402B2 (ja) 2014-02-26
US20060167245A1 (en) 2006-07-27
AU2006206421B2 (en) 2010-12-16
EP1838715B1 (de) 2010-10-27
PT1838715E (pt) 2011-01-27
WO2006078809A3 (en) 2007-07-12
JP2008528493A (ja) 2008-07-31
DK1838715T3 (da) 2011-02-14
AU2006206421A1 (en) 2006-07-27
ATE486077T1 (de) 2010-11-15
WO2006078809A2 (en) 2006-07-27
ES2355153T3 (es) 2011-03-23

Similar Documents

Publication Publication Date Title
DE602006017797D1 (de)
SI1928503T1 (sl) Postopek za pripravo konjugatov majtansinoid protitelo
AU305949S (en) A headlight for an automobile
EP2595149A3 (de) Vorrichtung zum Transkodieren von Downmix-Signalen
WO2011072199A3 (en) Water-soluble degradable photo-crosslinker
MX2008013594A (es) Reduccion estereoselectiva de una morfinona.
EP2270037A3 (de) Hasyliertes Faktor IX
WO2007126727A3 (en) WATER SOLUBLE β-GLUCAN, GLUCOSAMINE, AND N-ACETYLGLUCOSAMINE COMPOSITIONS AND METHODS FOR MAKING THE SAME
UA95959C2 (en) Leptomycin derivatives
WO2005085458A3 (en) Polyacetal-peptide mediated transfection
WO2007021960A3 (en) Polymer compositions and processes for making and using same
AU309523S (en) Front cover for four wheel vehicle
AU2006285712A1 (en) Method of producing saccharide composition starting with biomass
AU309251S (en) A rear gate for an automobile
CA112556S (en) Lighted post
IL188603A0 (en) Preparation of insulin conjugates
AU309260S (en) A front bumper for an automobile
AU309255S (en) A front bumper for an automobile
TW200609268A (en) Composition comprising titanium and clay and process therewith
AU309254S (en) A rear bumper for an automobile
AU305964S (en) Front top cover for a vehicle
ES2577433T3 (es) Conjugados éster de alfa aminoácido-fármaco hidrolizables por la carboxilesterasa
AU307593S (en) Front bumper for an automobile
AU303068S (en) Front bumper for an automobile
AU307594S (en) Rear bumper for an automobile